Prokidney Corp (PROK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -151,612 | -110,760 | -74,917 | -37,952 | -163,335 |
| Depreciation Amortization | 6,575 | 4,738 | 3,065 | 1,600 | 5,432 |
| Accounts payable and accrued liabilities | -5,919 | -8,075 | -8,126 | -5,902 | 11,592 |
| Other Working Capital | 1,281 | 524 | -778 | 1,113 | 3,956 |
| Other Operating Activity | 29,558 | 25,969 | 19,748 | 11,549 | 16,004 |
| Operating Cash Flow | $-120,117 | $-87,604 | $-61,008 | $-29,592 | $-126,351 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 3,019 | -9,444 | -4,247 | -1,135 | -29,509 |
| Purchase Of Investment | -217,076 | -176,676 | -98,138 | -55,449 | -324,023 |
| Sale Of Investment | 318,022 | 261,992 | 149,239 | 84,873 | 373,946 |
| Investing Cash Flow | $103,965 | $75,872 | $46,854 | $28,289 | $20,414 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -26 | -21 | -26 | -12 | -54 |
| Common Stock Issued | 25,595 | 7,956 | N/A | N/A | 144,462 |
| Financing Cash Flow | $25,569 | $7,935 | $-26 | $-12 | $144,408 |
| Beginning Cash Position | 99,120 | 99,120 | 99,120 | 99,120 | 60,649 |
| End Cash Position | 108,537 | 95,323 | 84,940 | 97,805 | 99,120 |
| Net Cash Flow | $9,417 | $-3,797 | $-14,180 | $-1,315 | $38,471 |
| Free Cash Flow | |||||
| Operating Cash Flow | -120,117 | -87,604 | -61,008 | -29,592 | -126,351 |
| Capital Expenditure | -15,196 | -9,444 | -4,247 | -1,135 | -29,509 |
| Free Cash Flow | -135,313 | -97,048 | -65,255 | -30,727 | -155,860 |